The winners of the state prizes of the Russian Federation in the field of science and technology are named
The State Prize of the Russian Federation for Science is innovative in nature – President of the Russian Academy of Sciences
The ceremony of announcing the decrees of Russian President Vladimir Putin on awarding the state prizes of the Russian Federation in the field of science and technology, as well as in the field of literature and art for 2011 took place on Friday in the Kremlin.
"All (award-winning) works are the clearest example when fundamental knowledge is used to obtain specific products," Osipov said in an interview with RIA Novosti on the sidelines of the ceremony.
The prize was awarded to Felix Mitrofanov, Chief Researcher of the Geological Institute of the Kola Scientific Center of the Russian Academy of Sciences, Academician of the Russian Academy of Sciences for scientific substantiation and discovery of large deposits of platinum-palladium ores on the Kola Peninsula. The awards were awarded to Academician, Chief Researcher of the Institute of Immunology of the FMBA of Russia Rem Petrov and director of this institute, Academician Rahim Khaitov for outstanding achievements in immunology, which allowed the creation of new drugs, including vaccines.
The prize will also be awarded to academicians Valery Charushin, Boris Trofimov and Oleg Chupakhin for their major contribution to the development of organic synthesis and the development of innovative technologies for the production of medicines.
Osipov noted that all the works of representatives of academic science marked by the state prize have a pronounced innovative character.
"Every time (in separate award cycles) there were works related to innovations, but that all three (academic) works (had a successful entry into practice) – this has never happened," Osipov said.
In particular, the work of Charushin, Trofimov and Chupakhin led to the creation of the antitumor drug "Lysomustin" and the antiviral drug "Triazavirin".
The Ural Center for Biopharmaceutical Technologies, which became one of the first participants of the Skolkovo project in December 2010, is engaged in the completion of clinical trials of Triazavirin, the chemical synthesis of new compounds based on its analogues and the evaluation of their antiviral effect. The basic development of the drug was carried out at the Postovsky Institute of Organic Synthesis of the Ural Branch of the Russian Academy of Sciences.
The 2011 State Prize was also awarded to the creators of radar stations of the missile attack warning system.
Portal "Eternal youth" http://vechnayamolodost.ru09.06.2012